Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

0.3985
+0.00390.99%
Volume:577.74K
Turnover:231.83K
Market Cap:4.49M
PE:-0.03
High:0.4076
Open:0.3900
Low:0.3900
Close:0.3946
Loading ...
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 22, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 18, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 25, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 22, 2020

Major Issues Report

8-K - Current report